Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates
Season 5, Episode 15, Aug 30, 02:45 PM
In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of using antibody-drug conjugates.